Social Return on Investment of an ideal approach to Multiple Sclerosis within the SNHS

Congress: ISPOR

Year: 2018

Desease: Neurological Disorders

Subject: Cost Studies

Subcategory:Cost Benefit Analysis

Objectives:Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system, characterized by progression and disability and a high impact on patients’ health-related quality of life. This study measures the Social Return on Investment (SROI) of the hypothetical implementation of an ideal approach to MS within the National Health System (NHS), from a clinical, health, economic and social perspective.